Bringing HIV care to the community: a new test in zambia

NCT ID NCT02776254

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study in Zambia is testing whether community-based and streamlined models of antiretroviral therapy (ART) care can help people living with HIV stay in treatment. It involves about 3,100 HIV-positive adolescents and adults who are not acutely ill. Participants may receive care through point-of-care testing for rapid ART initiation, community or urban adherence groups, or prescription refills. The goal is to see if these approaches improve retention in care and are acceptable, feasible, and cost-effective compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Differentiated care models for antiretroviral therapy (ART) delivery, including point-of-care testing, community adherence groups, and prescription refills
What this could lead to
If successful, this could show that community-based ART delivery is a practical way to keep more people with HIV in care, potentially improving long-term health and reducing transmission.
What could go wrong
The study is observational in nature and focuses on feasibility and implementation, so it may not prove which model works best. Results may also depend on local context and may not generalize to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Infectious Disease Research in Zambia

    Lusaka, Lusaka Province, 10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.